Jefferson Shreve bought AbbVie Inc (NYSE: ABBV)
Jefferson Shreve (R-IN), a U.S. Representative, has disclosed 2 trades in AbbVie Inc (ABBV) since 2025, 1 purchase and 1 sale, worth an estimated $150K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Jefferson Shreve bought $50,001 - $100,000 of AbbVie Inc (NYSE: ABBV) on February 24, 2025. Since that trade, ABBV is up +31.44% against the S&P 500 up +26.00%, an outperformance of +5.45%.
Across these filings, Jefferson Shreve has been a balanced trader of ABBV (a buy-to-sell ratio of 1.00). The most recent disclosed ABBV transaction shown was dated April 17, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Jefferson Shreve's ABBV trades vs the price
ABBV is up +31.44% since Jefferson Shreve bought on February 24, 2025, versus +26.00% for the S&P 500.
Performance since this trade
All Jefferson Shreve ABBV trades
Jefferson Shreve & ABBV trading FAQ
Is it legal for Jefferson Shreve to trade AbbVie Inc (ABBV) stock?
Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Jefferson Shreve buy ABBV?
Jefferson Shreve disclosed a purchase of $50,001 - $100,000 of AbbVie Inc (ABBV) on February 24, 2025, according to public STOCK Act filings.
How has ABBV performed since Jefferson Shreve's trade?
Since Jefferson Shreve bought ABBV on February 24, 2025, the stock is up +31.44%, versus +26.00% for the S&P 500 over the same period, an outperformance of +5.45%.
How many times has Jefferson Shreve traded ABBV?
Jefferson Shreve has disclosed 2 ABBV trades since 2025 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ABBV trades?
Quantellect tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.
Jefferson Shreve's ABBV tradesAll congressional filings for AbbVie IncJefferson Shreve's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.